Navigation Links
Study identifies new genetic signatures of breast cancer drug resistance
Date:1/10/2011

A new study conducted by Josh LaBaer's research team in the Biodesign Institute at Arizona State University has pinpointed more than 30 breast cancer gene targets ---including several novel genes---that are involved in drug resistance to a leading chemotherapy treatment.

The results of the study may one day aid in the treatment of the one in ten U.S. women who will develop breast cancer, by empowering physicians with a more personalized approach to therapy as well as a new tool for the early screening of those that may ultimately become resistant to chemotherapy.

Drugs like tamoxifen have been part of the standard treatment regimen for many breast cancer patients and saved countless lives. Unfortunately, a very serious therapeutic problem can occur when the drug loses its potency over time as women develop a resistance to the drug treatment, and tumors reemerge. Tamoxifen is an effective treatment for the 60 percent of women who are clinically diagnosed as ER+ (estrogen receptor positive), blocking hormones needed for tumor growth.

"The management of breast cancer is complicated, depending on the stage, size of tumor, and other things, but almost all ER+ women end up on tamoxifen, and it is still considered the first line of adjuvant chemotherapy ---along with resection and local radiation---used in both the early treatment of breast cancer and in late stages of the disease," said LaBaer, who holds the Virginia G. Piper Chair in Personalized Medicine at ASU and is director of the Center for Personalized Diagnostics at the Biodesign Institute. "We wanted to use a model where we could use our high-throughput technology to identify genes that encourage drug resistance to ultimately identify a signature that predicts which women will do well on a particular drug."

Using a well-established cell model for breast cancer along with the LaBaer lab's extensive collection of fully sequenced human genes, the team performed the larges
'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Study estimates land available for biofuel crops
2. Researchers brave icy waters to study Arctic food web
3. Lake Erie hypoxic zone doesnt affect all fish the same, study finds
4. College students lack scientific literacy, study finds
5. Study finds energy limits global economic growth
6. UF study of lice DNA shows humans first wore clothes 170,000 years ago
7. Catfish study reveals multiplicity of species
8. MIT researchers study the danger of toxoplasma parasites
9. Large-scale study reveals major decline in bumble bees in the US
10. CHOP-led study detects dozens of genes for adult height
11. Penn Medicine researcher receives $6 million grant for cardiovascular disease study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study identifies new genetic signatures of breast cancer drug resistance
(Date:9/30/2014)... (September 30, 2014) People who suffer from asthma ... to control their asthma besides properly taking medications and ... article in the Annals of Allergy, Asthma and ... of Allergy, Asthma and Immunology (ACAAI), asthma sufferers can ... lifestyle. The woman described in the Annals article improved ...
(Date:9/29/2014)... the exposure to tar tended to be lower for ... Similarly, exposure to nicotine tended to be lower. , ... in several countries around the world. Previous studies have ... the smoke of these cigarettes are lower than those ... in the smoke are not necessarily linked to a ...
(Date:9/29/2014)... a NASA story from 2009, "human activities in this area ... issue. Palm oil is increasingly grown for use as a ... processed foods. It has become the most widely produced edible ... years to surpass that of soybean oil. , The environmental ... be cleared to grow the crop, and the preferred method ...
Breaking Biology News(10 mins):Asthma symptoms kicking up? Check your exposure to air pollution 2Slim cigarette smokers not exposed to more harmful chemicals 2
... Bacteria can directly cause human blood and plasma to ... lost during the course of vertebrate evolution, according to ... of Allergy and Infectious Diseases, and Institut Pasteur in ... in Nature Chemical Biology . , The discovery ...
... designing and manufacturing biomedical sensors, healthcare and its related ... learn what to expect from this new and growing ... seminar set for Nov. 6, 2008, from 4:45-6 p.m., ... (ECE) Building, 141 Warren St, at the northwest corner ...
... in Italy have found bacteria in the root of ... the cosmetic and perfumery industries. These bacteria seem to ... change the molecular structure of the oil, giving it ... Studying the root of the tropical Vetiver grass ...
Cached Biology News:Nature study demonstrates that bacterial clotting depends on clustering 2NJIT seminar set for Nov. 6 to focus on bioelectronics -- emerging research area 2Bacteria manage perfume oil production from grass 2
(Date:10/1/2014)... New applications of structures and materials that ... nature over millennia are featured in a special ... in biophotonics in the October issue of the ... by SPIE, the international society for optics and photonics, ... articles are accessible via open access. , “Biomimetic and ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Slone ... Clinical Therapeutics, Healthcare IT, and Laboratory Testing industries, reported ... positions at the director level and above from July ... to stay on top of rapid breakthroughs in diagnostics, ... many diagnostic companies have been forced to fold, consolidate, ...
(Date:10/1/2014)... The U.S. Department of Labor has awarded ... as part of the Trade Adjustment Assistance Community College ... by the Department of Labor and Department of Education. ... E. Perez and Secretary of Education Arne Duncan announced ... to nearly 270 colleges across the country. , ...
(Date:10/1/2014)... Industry leaders from retail ... around the theme, ,Commercial Opportunities in the Era of ... Elsevier , a world-leading provider of scientific, ... a gathering of some of the industry,s most prominent ... today and in the future. The Elsevier ...
Breaking Biology Technology:Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3
... 2011 Debiopharm Group™ (Debiopharm), a ... drug development and companion diagnostics, will present tomorrow ... Professor Stefano Piccolo as well as two inaugural ... Professor Etienne Meylan and Doctor Volker Busskamp. The ...
... of the INRS,s Energy, Materials, and Telecommunications Centre, has ... Medal in Chemistry. Granted by the Royal Society of ... major breakthroughs in the fields of molecular self-assembly and ... Dr. Rosei has held the Canada Research ...
... 7, 2011 CMC Biologics and Oxford BioTherapeutics (OBT) ... license agreement providing OBT with access to CMC Biologics, ... have not been disclosed, covers the research, development, and ... CHEF1 cell line development platform promotes high level expression ...
Cached Biology Technology:Debiopharm Group™ Presents the 'Debiopharm Group™ Life Sciences Award 2011' and two 'Junior Debiopharm Group™ Awards 2011' at the ISREC 2011 Life Sciences Symposium 2Debiopharm Group™ Presents the 'Debiopharm Group™ Life Sciences Award 2011' and two 'Junior Debiopharm Group™ Awards 2011' at the ISREC 2011 Life Sciences Symposium 3CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics 2CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics 3CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics 4
... The MBS Satellite Thermal ... and flexible solution for medium ... The MBS combines the latest ... friendly software and PC control, ...
45° Fixed Angle Rotor for use in the IEC Centra CL2, Centra CL3/CL3R, HN-SII, and the Centra-MP4/MP4R....
Glycerokinase; from Bacillus stearothermophilus...
...
Biology Products: